Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
Agilent
Boston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Borrow Rate - Xã Thanh Hà
Agilent
Is Agilent Technologies a Better Buy Than Danaher? - Trefis
Lonza News
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo Finance
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
Agilent
Boston Trust Walden Corp Sells 21,880 Shares of Agilent Technologies, Inc. $A - MarketBeat
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Borrow Rate - Xã Thanh Hà
Agilent
Is Agilent Technologies a Better Buy Than Danaher? - Trefis
Lonza News
Is Lonza Group (SWX:LONN) Pricing Too High After Recent Share Price Swings? - Yahoo Finance
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioWorld
Total
1071
Source
BioWorld
Recherche
--
BioWorld
28 janv. 2026
Di’ao Group Chengdu Pharmaceutical identifies GLP-1R agonists
BioWorld
27 janv. 2026
Former Cytodyn CEO faces prison time, millions in restitution
BioWorld
27 janv. 2026
Appointments and advancements for Jan. 27, 2026
BioWorld
27 janv. 2026
Financings for Jan. 27, 2026
BioWorld
27 janv. 2026
In the clinic for Jan. 27, 2026
BioWorld
27 janv. 2026
Other news to note for Jan. 27, 2026
BioWorld
27 janv. 2026
Regulatory actions for Jan. 27, 2026
BioWorld
27 janv. 2026
Maresin 1 improves cardiac function after myocardial infarction
BioWorld
27 janv. 2026
University of Sydney discloses coagulation factor XIa inhibitors
BioWorld
27 janv. 2026
University of Kansas identifies TNF-α/HuR interaction inhibitors
BioWorld
27 janv. 2026
Korean researchers discover new HBV PreS1 derivatives
BioWorld
26 janv. 2026
Med-tech gainers and losers for Jan. 19-23, 2026
BioWorld
26 janv. 2026
Financings for Jan. 26, 2026
BioWorld
26 janv. 2026
In the clinic for Jan. 26, 2026
BioWorld
26 janv. 2026
Other news to note for Jan. 26, 2026
BioWorld
26 janv. 2026
Regulatory actions for Jan. 26, 2026
BioWorld
26 janv. 2026
Biggest gainers and losers for Jan. 19-23, 2026
BioWorld
26 janv. 2026
ROCK inhibitors disclosed in Avicenna Biosciences patents
Précédent
35 / 60
Suivant